HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent cholestasis resulting from duodenal papillary carcinoma in an adolescent male: A case report.

AbstractRATIONALE:
Cholestasis in pediatric patients has diverse etiologies and can be broadly classified as intrahepatic or extrahepatic. The common causes of extrahepatic cholestasis are bile duct calculus, inflammation, or pancreatitis. Malignant tumor is a rare cause of bile ducts obstruction in adolescent. Here we report a 14-year-old male patient with cholestasis due to poorly differentiated adenocarcinoma.
PATIENT CONCERNS:
A 14-year-old male patient with cholestasis was admitted because of jaundice, weakness, weight loss, and stomach pain for 2 months. The patient had been diagnosed with epilepsy 4 years previously and was being treated with sodium valproate and oxcarbazepine. On admission, laboratory studies showed elevated levels of aspartate aminotransferase (271 IU/L), alanine aminotransferase (224 IU/l), γ-glutamyltransferase (1668.9 IU/L), total bilirubin (66.4 μmol/L), and direct bilirubin (52.6 μmol/L). Additional laboratory tests eliminated common causes of cholestasis such as bacterial/viral infection, autoimmune liver disease, Wilson disease, Alagille syndrome, or progressive familial intrahepatic cholestasis type 3. The results of laboratory investigations showed no improvement after 10 days of treatment with ursodeoxycholic acid and vitamins A, D, and K1. Enhanced magnetic resonance imaging demonstrated a tumor of 22 mm diameter in the duodenal lumen and dilatation of the common bile duct. Endoscopic retrograde cholangiopancreatography detected a tumor in the duodenal lumen.
DIAGNOSIS:
Considering the clinical features, imaging manifestation, endoscopic findings, and pathologic characteristic, the patient was diagnosed with poorly differentiated adenocarcinoma.
INTERVENTIONS:
The patient underwent pancreaticoduodenectomy and chemotherapy.
OUTCOME:
The patient recovered well. Elevated levels of tumor biomarkers or abnormal liver function tests have not occurred during the 2-year follow-up.
CONCLUSION:
Cholestasis resulting from primary duodenal papillary carcinoma is rare in pediatric patients but should be considered in the differential diagnosis.
AuthorsHaiyan Fu, Yingchao Li, Gelan Bai, Runkai Yin, Chunlan Yin, Weina Shi, Lili Zhang, Rongpin Li, Ruiqin Zhao
JournalMedicine (Medicine (Baltimore)) Vol. 98 Issue 22 Pg. e15708 (May 2019) ISSN: 1536-5964 [Electronic] United States
PMID31145285 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Ampulla of Vater (pathology)
  • Carcinoma, Papillary (complications, pathology)
  • Cholestasis (etiology, pathology)
  • Duodenal Neoplasms (complications, pathology)
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: